Embedded Files
8:00 AM
8:00 AM
CHICK-IN & REGISTRATION
CHICK-IN & REGISTRATION
8:30 AM
8:30 AM
KEYNOTE SESSION
KEYNOTE SESSION
Room #1 8:30am
WELCOME BACK & ADMINISTRATION
WELCOME BACK & ADMINISTRATION
DOPL or Utah Office of Substance Use & Mental Health
THE ASAM CRITERIA & THE FUTURE OF ADDICTION CARE IN THE U.S.
THE ASAM CRITERIA & THE FUTURE OF ADDICTION CARE IN THE U.S.
R. Corey Waller, MD, MS, DFASAM
9:35 AM
9:35 AM
BREAK
BREAK
9:45 AM
9:45 AM
BREAKOUT SESSIONS
BREAKOUT SESSIONS
Room #1 9:45am
FENTANYL UPDATE & CURRENT TRENDS
Gil Van Attenhoven
Room #2 9:45am
A DEEPER DIVE INTO THE NEW ASAM WORLD
A DEEPER DIVE INTO THE NEW ASAM WORLD
R. Corey Waller, MD, MS, DFASAM
Room #3 9:45am
SUBOXONE IN THE AGE OF FENTANYL – CONSIDERATIONS IN ACUTE SETTINGS
SUBOXONE IN THE AGE OF FENTANYL – CONSIDERATIONS IN ACUTE SETTINGS
Jeffery Clark, MD; Robert J. Mendenhall, DO Mason Turner, MD; Benjamin Todd Thatcher, DO, CMRO (Moderator)
Room #4 9:45am
THE PITFALLS & PERILS OF PROFESSIONAL IMPAIRMENT
THE PITFALLS & PERILS OF PROFESSIONAL IMPAIRMENT
Michael Baron, MD, MPH, DFASAM
11:00 AM
11:00 AM
BREAK
BREAK
11:15 AM
11:15 AM
BREAKOUT SESSIONS
BREAKOUT SESSIONS
Room #1 11:15am
METHAMPHETAMINE UPDATE & CURRENT TRENDS
METHAMPHETAMINE UPDATE & CURRENT TRENDS
Gil Van Attenhoven
Room #2 11:15am
DIY PSYCHOTHERAPY: THE NUTS & BOLTS FIRST
DIY PSYCHOTHERAPY: THE NUTS & BOLTS FIRST
Spencer Hansen, MD
Room #3 11:15am
SUBOXONE IN THE AGE OF FENTANYL – CONSIDERATIONS IN NON-ACUTE SETTINGS
SUBOXONE IN THE AGE OF FENTANYL – CONSIDERATIONS IN NON-ACUTE SETTINGS
Jeffery Clark, MD; Robert J. Mendenhall, DO Mason Turner, MD; Benjamin Todd Thatcher, DO, CMRO (Moderator)
Room #4 11:15am
ADDRESSING SUBSTANCE USE DISORDERS WITHIN PHYSICAL MEDICINE & REHABILITATION POPULATIONS
ADDRESSING SUBSTANCE USE DISORDERS WITHIN PHYSICAL MEDICINE & REHABILITATION POPULATIONS
Jess Farrar, PhD; Jenny Jones-Medina, PhD; Jordan Kwamanakweenda, PsyD
12:30 PM
12:30 PM
LUNCH & ACUDETOX STATIONS
LUNCH & ACUDETOX STATIONS
1:30 PM
1:30 PM
BREAKOUT SESSIONS
BREAKOUT SESSIONS
Room #1 1:30pm
SOBER TALK ABOUT KETAMINE
SOBER TALK ABOUT KETAMINE
Wendy Johnson; Larry Marx, MPA; Mason Turner, MD
Room #2 1:30pm
MEDICAL COMPLICATIONS OF SUBSTANCE USE
MEDICAL COMPLICATIONS OF SUBSTANCE USE
Jonathan Watson, MD
Room #3 1:30pm
CANNABIS USE & THE ROLE OF ADOLESCENT DEVELOPMENT IN SUBSTANCE USE TREATMENT
CANNABIS USE & THE ROLE OF ADOLESCENT DEVELOPMENT IN SUBSTANCE USE TREATMENT
Mario Lintz, MD; Mtn Plains ATTC
Room #4 1:30pm
ELEPHANT IN THE ROOM: STIGMA & ITS IMPACT IN CLINICAL CARE
ELEPHANT IN THE ROOM: STIGMA & ITS IMPACT IN CLINICAL CARE
Michael Baron, MD, MPH, DFASAM
2:45 PM
2:45 PM
BREAK
BREAK
3:00 PM
3:00 PM
BREAKOUT SESSIONS
BREAKOUT SESSIONS
Room #1 3:00pm
THE IMPACT OF LONELINESS ON SUBSTANCE USE: THE POWER OF CONNECTEDNESS
THE IMPACT OF LONELINESS ON SUBSTANCE USE: THE POWER OF CONNECTEDNESS
Steven G. Sugden, MD, MPH
Room #2 3:00pm
MIND PIVOT: INTEGRATING NUTRITIONAL INTERVENTIONS FOR HEALING BODY & MIND IN RECOVERY
Amy de la Garza, MD, FASAM, IFMCP; Catherine Van Tassell, LCSW, PA-C, DipACLM
Room #3 3:00pm
IMPROVING COMPLIANCE THORUGH MOTIVATIONAL INTERVIEWING
IMPROVING COMPLIANCE THORUGH MOTIVATIONAL INTERVIEWING
Denise N. Lash, PhD
Room #4 3:00pm
NAVIGATING THE TRANSITION: STRATEGIES FOR INCORPORATING LONG-ACTING INJECTABLE BUPRENORPHINE INTO PRACTICE
NAVIGATING THE TRANSITION: STRATEGIES FOR INCORPORATING LONG-ACTING INJECTABLE BUPRENORPHINE INTO PRACTICE
Anthony May, PharmD, MBA
Page updated
Report abuse